Edinburgh Research Explorer Common variants at 10 genomic loci influence hemoglobin A(C) levels via glycemic and nonglycemic pathways
暂无分享,去创建一个
Christian Gieger | Nicole Soranzo | Josée Dupuis | Muredach P. Reilly | Claudia Langenberg | Inga Prokopenko | Serena Sanna | Eleanor Wheeler | Manjinder S. Sandhu | Dörte Radke | C. Gieger | W. McArdle | M. Reilly | G. Willemsen | J. Peden | S. Ripatti | M. Sandhu | K. Mohlke | B. Voight | R. Sladek | G. Rocheleau | J. Dupuis | C. Willenborg | I. Prokopenko | N. Soranzo | C. Langenberg | N. Bouatia-Naji | S. Sanna | R. Strawbridge | D. Radke | E. Wheeler | C. Lecoeur | Kuusisto | Olla | J. Devaney | M. Heeney | A. Mälarstig | Nabila Bouatia-Naji | Joseph M. Devaney | S. Ricketts | Matthew M. Heeney | Lyssenko | E. Stolerman | Elliot Stolerman | Sally L. Ricketts | Leif | Groop | S. | Meisinger | Stephen E. Epstein | Pankow | Ozren | Polašek | Felicity | Leena | Nathan | Mooser | Narisu Narisu | M. Morken | M. Sandhu | Surakka | Usala | Markku Laakso | Ruth J. F. Loos | Hugh Watkins | Kari Stefansson | Nancy L. Pedersen | Michael Stumvoll | Eleonora Porcu | Inga | Prokopenko | P. Muredach | Reilly | Knut | Krohn | Brigitte | Kühnel | Johanna | Valeriya | Ruth | McPherson | Christa | Olle Melander | E. Vincent | M. David | Chris O’Donnell | Konrad | Oexle | Nazario | James | Payne | Peltonen | Markus | Perola | Daniel J. Rader | Richa | Saxena | P. David | Strachan | Ida | Gianluca | Winkelmann | Erdmann | W. H. Kao | Caroline S. Fox | Matthias Nauck | M. McCarthy | Dawn M. Waterworth | Mark Lathrop | Jeanette | Juliane | Massimo Mangino | J. Zhao | J. Luan | Winfried März | R. Mägi
[1] C. Gieger,et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis (vol 42, pg 579, 2010) , 2011 .
[2] Ayellet V. Segrè,et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.
[3] Alex Doney,et al. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge , 2010, Nature Genetics.
[4] Christian Gieger,et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk , 2010, Nature Genetics.
[5] P. Zimmet,et al. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.
[6] Christian Gieger,et al. A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium , 2009, Nature Genetics.
[7] Christian Gieger,et al. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium , 2009, Nature Genetics.
[8] P. Elliott,et al. Genetic Variant in HK1 Is Associated With a Proanemic State and A1C but Not Other Glycemic Control–Related Traits , 2009, Diabetes.
[9] J. Shaw,et al. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.
[10] M. Laakso,et al. Association of 18 Confirmed Susceptibility Loci for Type 2 Diabetes With Indices of Insulin Release, Proinsulin Conversion, and Insulin Sensitivity in 5,327 Nondiabetic Finnish Men , 2009, Diabetes.
[11] Mark I McCarthy,et al. Genome-wide association studies in type 2 diabetes , 2009, Current diabetes reports.
[12] L. Groop,et al. A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals , 2009, Diabetologia.
[13] F. Brancati,et al. Elevated A1C in Adults Without a History of Diabetes in the U.S. , 2009, Diabetes Care.
[14] P. Elliott,et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk , 2009, Nature Genetics.
[15] D. Altshuler,et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion , 2009, Nature Genetics.
[16] Inês Barroso,et al. Variants in MTNR1B influence fasting glucose levels , 2009, Nature Genetics.
[17] N. Stefan,et al. Polymorphisms within the Novel Type 2 Diabetes Risk Locus MTNR1B Determine β-Cell Function , 2008, PloS one.
[18] Jerry Kaplan,et al. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. , 2008, Cell metabolism.
[19] P. Ridker,et al. Novel Association of HK1 with Glycated Hemoglobin in a Non-Diabetic Population: A Genome-Wide Evaluation of 14,618 Participants in the Women's Genome Health Study , 2008, PLoS genetics.
[20] C. Lindsell,et al. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. , 2008, Blood.
[21] M. Rieder,et al. Common Missense Variant in the Glucokinase Regulatory Protein Gene Is Associated With Increased Plasma Triglyceride and C-Reactive Protein but Lower Fasting Glucose Concentrations , 2008, Diabetes.
[22] D. Lawlor,et al. Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. , 2008, The Journal of clinical investigation.
[23] Jean Tichet,et al. A Polymorphism Within the G6PC2 Gene Is Associated with Fasting Plasma Glucose Levels , 2008, Science.
[24] N. Andrews,et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA) , 2008, Nature Genetics.
[25] N. Mohandas,et al. Disorders of red cell membrane , 2008, British journal of haematology.
[26] Peter M. Jones,et al. Function and expression of melatonin receptors on human pancreatic islets , 2008, Journal of pineal research.
[27] N. Andrews,et al. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. , 2008, Cell metabolism.
[28] M. Pencina,et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.
[29] T. Nielsen,et al. The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes , 2007, Diabetologia.
[30] Evangelos Evangelou,et al. Heterogeneity in Meta-Analyses of Genome-Wide Association Investigations , 2007, PloS one.
[31] P. Donnelly,et al. A new multipoint method for genome-wide association studies by imputation of genotypes , 2007, Nature Genetics.
[32] Yurii S. Aulchenko,et al. BIOINFORMATICS APPLICATIONS NOTE doi:10.1093/bioinformatics/btm108 Genetics and population analysis GenABEL: an R library for genome-wide association analysis , 2022 .
[33] H. Dralle,et al. Melatonin and type 2 diabetes – a possible link? * , 2007, Journal of pineal research.
[34] D. Melzer,et al. A common haplotype of the glucokinase gene alters fasting glucose and birth weight: association in six studies and population-genetics analyses. , 2006, American journal of human genetics.
[35] G. Abecasis,et al. Heritability of Cardiovascular and Personality Traits in 6,148 Sardinians , 2006, PLoS genetics.
[36] D. Vertommen,et al. Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites. , 2006, Diabetes & metabolism.
[37] F. Chatonnet,et al. Cloning and analysis of Nkx6.3 during CNS and gastrointestinal development. , 2006, Gene expression patterns : GEP.
[38] N. Heisterkamp,et al. Resistance to farnesyltransferase inhibitors in Bcr/Abl-positive lymphoblastic leukemia by increased expression of a novel ABC transporter homolog ATP11a. , 2005, Blood.
[39] R. Little,et al. Effects of hemoglobin C and S traits on glycohemoglobin measurements by eleven methods. , 2005, Clinical chemistry.
[40] M. Olivier. A haplotype map of the human genome. , 2003, Nature.
[41] B. Szwergold,et al. The expression of the genes for fructosamine-3-kinase and fructosamine-3-kinase-related protein appears to be constitutive and unaffected by environmental signals. , 2004, Biochemical and biophysical research communications.
[42] N. Pørksen. Early changes in beta-cell function and insulin pulsatility as predictors for type 2 diabetes. , 2002, Diabetes, nutrition & metabolism.
[43] T. Frayling,et al. Intrauterine hyperglycemia is associated with an earlier diagnosis of diabetes in HNF-1alpha gene mutation carriers. , 2002, Diabetes care.
[44] F. Collard,et al. Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytes. , 2002, The Biochemical journal.
[45] P. Wilson,et al. A Genome-Wide Scan for Loci Linked to Plasma Levels of Glucose and HbA1c in a Community-Based Sample of Caucasian Pedigrees: The Framingham Offspring Study , 2002 .
[46] G L Myers,et al. The national glycohemoglobin standardization program: a five-year progress report. , 2001, Clinical chemistry.
[47] E. Schaftingen,et al. Conversion of a synthetic fructosamine into its 3-phospho derivative in human erythrocytes. , 2000, The Biochemical journal.
[48] K. Roeder,et al. Genomic Control for Association Studies , 1999, Biometrics.
[49] Marc Montminy,et al. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus , 1999, Nature Genetics.
[50] N. Nomura,et al. Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. , 1999, DNA research : an international journal for rapid publication of reports on genes and genomes.
[51] S. Hayette,et al. Two distinct truncated variants of ankyrin associated with hereditary spherocytosis , 1998, American journal of hematology.
[52] M. Corsetti,et al. Prevalence of Genetic Hemochromatosis in a Cohort of Italian Patients with Diabetes Mellitus , 1998, Annals of Internal Medicine.
[53] F M Matschinsky,et al. Familial hyperinsulinism caused by an activating glucokinase mutation. , 1998, The New England journal of medicine.
[54] S. Piomelli,et al. Identification of the cDNA for human red blood cell-specific hexokinase isozyme. , 1997, Blood.
[55] B. Forget,et al. Ankyrin–1 mutations are a major cause of dominant and recessive hereditary spherocytosis , 1996, Nature Genetics.
[56] M. Magnani,et al. Hexokinase mutations that produce nonspherocytic hemolytic anemia. , 1995, Blood cells, molecules & diseases.
[57] S. Reppert,et al. Melatonin madness , 1995, Cell.
[58] P. Hall,et al. PREVALENCE OF GENETIC HAEMOCHROMATOSIS AMONG DIABETIC PATIENTS , 1989, The Lancet.
[59] H. Mortensen,et al. Glucosylation of human haemoglobin a in red blood cells studied in vitro. Kinetics of the formation and dissociation of haemoglobin A1c. , 1983, Clinica chimica acta; international journal of clinical chemistry.
[60] J. Akkerman,et al. Generalized hexokinase deficiency in the blood cells of a patient with nonspherocytic hemolytic anemia. , 1983, Blood.
[61] E. Neumann,et al. Glycosylated hemoglobins (GHb): an index of red cell survival. , 1982, Blood.